EUVIMEDEUVIMED entdecken
Crossref

Ex Utero Intrapartum Treatment for Prenatally Diagnosed Cervicofacial Lymphatic Malformations

Srinithya R Gillipelli, Sarah E Peiffer, Shannon M Larabee, Pamela Ketwaroo, Kristy L Rialon, Joshua Bedwell, Deepak Mehta, Timothy C Lee, Sundeep G Keswani, Alice King

Journal of Surgical Research · 2024-11 · 303 · 628-635

DOI: 10.1016/j.jss.2024.08.026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Surgical Research, 2024-11. Verfasst von Srinithya R Gillipelli und 9 weiteren Autor:innen. Beteiligte Einrichtung: Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas; Division of Pediatric Surgery, Department of Surgery, Texas Chi…. Hauptthemen laut MEDLINE: Lymphatic Abnormalities, Ultrasonography, Prenatal. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 38 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Cervicofacial lymphatic malformations (cf-LM) may be identified on prenatal ultrasound, prompting consideration of ex utero intrapartum treatment (EXIT) to secure the fetal airway. Furthermore, the recent shift in postnatal management of cf-LM from resection alone toward a multimodal approach including sirolimus and sclerotherapy may impact the neonatal outcomes of cf-LM. This study aims to characterize the neonatal outcomes of patients with prenatally diagnosed cf-LM who underwent EXIT-to-airway. METHODS: Retrospective, single-center review of all patients who underwent EXIT-to-airway for cf-LM (2011-2020) was performed. Demographics, prenatal imaging, intraoperative details, and outcomes were analyzed using descriptive statistics (median [interquartile range]). RESULTS: Six patients with prenatally diagnosed cf-LM underwent EXIT-to-airway at a median gestational age of 36 (33.8-36.9) wk. The median volume on fetal magnetic resonance imaging was 187.5 mL (142.3-237.8) and median tracheoesophageal displacement index was 11 mL (9.25-15). All were successfully intubated on placental support with a median duration of 25 (15.25-91) d. There was one fatality at day of life 10 due to necrotizing enterocolitis totalis. Among survivors, 2 of 5 underwent tracheostomy placement, 4 of 5 underwent gastrostomy tubes placement, and all 5 received sirolimus at day of life of 9 [8-10] d. Four patients underwent debulking or excision of their cf-LM during the initial hospitalization. Patients had a median length of stay of 68 (45-129) d. One patient experi enced a pneumothorax with evidence of barotrauma following EXIT-to-airway requiring chest tube placement (duration 8 d). CONCLUSIONS: EXIT-to-airway procedure remains a feasible strategy for mitigating neonatal hypoxia in cases of prenatally diagnosed cervicofacial lymphatic malformations. However, postnatal outcomes are variable with potential long-term aerodigestive sequelae.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lymphatic AbnormalitiesUltrasonography, PrenatalHumansFemalePregnancyRetrospective StudiesInfant, NewbornAdultMagnetic Resonance ImagingGestational AgeSclerotherapyNeckMaleTreatment OutcomeSirolimus

Stichwörter der Autor:innen

Cervicofacial lymphatic malformationEx utero intrapartum treatment (EXIT)Multimodal managementNeonatal outcomesPediatric surgeryPerinatal care

Substanzen

Sirolimus

Autor:innen und Institutionen

  • Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas; Division of Pediatric Surgery, Department of Surgery, Texas Children's Hospital, Houston, Texas.
  • Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas; Division of Pediatric Surgery, Department of Surgery, Texas Children's Hospital, Houston, Texas. Electronic address: axking3@texaschi…

Zitieren

APA

Gillipelli, S. R., Peiffer, S. E., Larabee, S. M., Ketwaroo, P., Rialon, K. L., Bedwell, J., Mehta, D., Lee, T. C., Keswani, S. G., & King, A. (2024). Ex Utero Intrapartum Treatment for Prenatally Diagnosed Cervicofacial Lymphatic Malformations. Journal of Surgical Research, 303, 628-635. https://doi.org/10.1016/j.jss.2024.08.026

Vancouver

Gillipelli SR, Peiffer SE, Larabee SM, Ketwaroo P, Rialon KL, Bedwell J, et al. Ex Utero Intrapartum Treatment for Prenatally Diagnosed Cervicofacial Lymphatic Malformations. Journal of Surgical Research. 2024;303:628-635. doi:10.1016/j.jss.2024.08.026

BibTeX
@article{Gillipelli2024,
  author = {Gillipelli, Srinithya R and Peiffer, Sarah E and Larabee, Shannon M and Ketwaroo, Pamela and Rialon, Kristy L and Bedwell, Joshua and Mehta, Deepak and Lee, Timothy C and Keswani, Sundeep G and King, Alice},
  title = {Ex Utero Intrapartum Treatment for Prenatally Diagnosed Cervicofacial Lymphatic Malformations},
  journal = {Journal of Surgical Research},
  year = {2024},
  volume = {303},
  pages = {628--635},
  doi = {10.1016/j.jss.2024.08.026}
}
Kostenlos starten →